News from regentis biomaterials ltd A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 16, 2013, 09:00 ET

Hydrogel Implant GelrinC Demonstrates Impressive Recovery Rates for Patients with Knee Cartilage Damage

Regentis Biomaterials announced today new clinical data demonstrating the efficacy and safety of its GelrinC implant for treating articular...

Sep 16, 2013, 04:00 ET

Hydrogelimplantaat GelrinC toont indrukwekkende herstelcijfers voor patiënten met beschadigingen aan kniekraakbeen

Behandeling toont potentieel als veilige en zeer effectieve oplossing voor letsel aan gewrichtskraakbeen Regentis Biomaterials maakte vandaag...

Sep 16, 2013, 04:00 ET

Les implants en hydrogel GelrinC affichent des taux de récupération impressionnants chez les patients souffrant de lésions du cartilage du genou

Le traitement se révèle être une solution sûre et hautement efficace pour traiter les lésions du cartilage...

Sep 16, 2013, 04:00 ET

L'impianto idrogel GelrinC mostra un rilevante indice di recupero nei pazienti con danno della cartilagine articolare del ginocchio

Nelle lesioni a carico della cartilagine articolare, il trattamento si è dimostrato potenzialmente sicuro e altamente efficace Regentis...

Sep 16, 2013, 04:00 ET

Hydrogelimplantat GelrinC zeigt beeindruckende Erholungssquoten bei Patienten mit Knieknorpelschäden

Behandlung zeigt Potenzial als sicheres und hochwirksames Mittel bei Gelenkknorpelverletzungen Regentis Biomaterials gab heute neue klinische...

Apr 10, 2013, 09:00 ET

Regentis Biomaterials Expands Clinical Study of GelrinC for Cartilage Repair

Regentis Biomaterials Ltd., a privately held company focused on developing proprietary hydrogels for tissue regeneration, announced today that it...

Mar 18, 2013, 09:00 ET

Regentis Biomaterials Receives European CE Mark Approval for GelrinC

Regentis Biomaterials Ltd., a privately held company focused on developing proprietary hydrogels for tissue regeneration, announced today it has...

May 14, 2012, 09:00 ET

Regentis Biomaterials Announces $10 Million Raised in Latest Round of Funding

Regentis Biomaterials Ltd., a privately held company focused on developing proprietary hydrogels for tissue regeneration, announced that it has...

May 14, 2012, 04:00 ET

Regentis Biomaterials verkündet eine Aufstockung in Höhe von zehn Millionen US-Dollar aus der jüngsten Finanzierungsrunde

Die Mittel sollen zur Ausweitung der klinischen Verwendung des innovativen Implantats zur Knorpelregeneration GelrinC™ verwendet...

May 14, 2012, 04:00 ET

Regentis Biomaterials kondigt aan dat het $ 10 miljoen bijeen heeft weten te krijgen in de laatste ronde van de financiering

Investering voor de uitbreiding van het klinisch gebruik van het innovatieve implantaat GelrinC™ voor de regeneratie van kraakbeen Regentis...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge